top of page

Skeletal Strengthening for DIABETES

Osteostrong DIabetes.png

OSTEOSTRONG CAN HELP WITH TYPE II DIABETES

There are multiple, well-proven, and safe approaches to treating type II diabetes and metabolic dysfunction. Fortunately, these different approaches can be used individually or in conjunction with one another. When viewed as single therapies, however, it is OsteoStrong that performs the best compared to the other standards of care in reducing HbA1c (long-term blood glucose measures).

​

diabetes2.jpg

TYPE II DIABETES STATISTICS

 

WHO TYPE II DIABETES AFFECTS

Type II diabetes (T2D) and pre-diabetes, also known as metabolic disease, affects nearly 100 million Americans (1 in 3 people). †

 

COSTS OF TREATMENT

Treatment costs exceed $322 billion per year.

 

HEALTHCARE & METABOLIC DISEASE

20% of all healthcare dollars are spent on metabolic disease.

​

For More Information On Bone Health & Diabetes

​

​

​

 

 

† Most estimates of diabetes in this report do not differentiate between type 1 and type 2 diabetes. However, because type 2 diabetes accounts for 90% to 95% of all diabetes cases, the data presented are likely to be more characteristic of type 2 diabetes.

BOOK YOUR COMPLIMENTARY CONSULTATION NOW

clock.png

Business Hours: 

Sunday: 10am- 1pm

Monday: closed

Tuesday: 9am- 3pm

Wednesday: 9am- 5pm

Thursday: 9am- 3pm

Friday: 9am- 3pm

Saturday:  closed

thumb.png
  • Instagram
facebook logo.png
Osteostrong black.png
home.png
phone.png
mail.png

Harbourview Shoppes

(second floor)

1500 Old Northern Blvd.

Roslyn, NY 11576

​

Tel: 516-682-2458

​

Roslyn@OsteoStrong.me

** No physical exercise is 100% safe, and neither is OsteoStrong. OsteoStrong provides a unique way to emulate a high impact load of force to achieve osteogenic loading, without the high impact. While not 100% safe, OsteoStrong is significantly safer than attempting high impact force. OsteoStrong members have reported improved bone density, improved balance, improved strength, reduced joint pain, and reduced HbA1c. Results may vary. Consult your physician. Statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition. OsteoStrong centers are independently owned and operated. OsteoStrong’s Science Advisor received his PhD from Rushmore University, certified/accredited in accordance with UK National Standards, but whose accreditation is not recognized in some jurisdictions. All rights reserved.

©2022 Osteostrong Roslyn

bottom of page